Juan B. Blaquier
Neurology
1475 Northwest 12th Avenue
Miami, FL 33136
Miami, FL 33136
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Expanding Lung Cancer Clinical Trial Criteria: A Systematic Review on Inclusion of Patients with Brain Metastases and Leptomeningeal Disease.
Journal: Clinical lung cancer
Published: May 30, 2025
Incorporating Targeted Therapy Into Neuro-Oncology Practice.
Journal: American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting
Published: April 11, 2025
Upfront osimertinib and as sequential therapy in patients with EGFR-mutant non-small cell lung cancer (NSCLC): benefit across patients groups in a real-world retrospective cohort-the smile study.
Journal: Translational lung cancer research
Published: September 23, 2024
Association Between Lung Immune Prognostic Index and Durvalumab Consolidation Outcomes in Patients With Locally Advanced Non-Small-Cell Lung Cancer.
Journal: Clinical lung cancer
Published: August 22, 2023
Genomic Landscape of Primary Resistance to Osimertinib Among Hispanic Patients with EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC): Results of an Observational Longitudinal Cohort Study.
Journal: Targeted oncology
Published: February 19, 2023
Tackling Osimertinib Resistance in EGFR-Mutant Non-Small Cell Lung Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: December 14, 2022
Osimertinib and chemotherapy combination to treat brain metastasis flare and osimertinib resistance by EGFR C797S.
Journal: Journal of chemotherapy (Florence, Italy)
Published: April 25, 2022
Coronavirus Disease 2019 Outcomes, Patient Vaccination Status, and Cancer-Related Delays During the Omicron Wave: A Brief Report From the TERAVOLT Analysis.
Journal: JTO clinical and research reports
Published: April 12, 2022
Mechanisms of Resistance to First-Line Osimertinib in Hispanic Patients With EGFR Mutant Non-Small Cell Lung Cancer (FRESTON-CLICaP).
Journal: Clinical lung cancer
Published: March 25, 2022
Non-small-cell lung cancer: how to manage MET exon 14 skipping mutant disease.
Journal: Drugs in context
Published: February 05, 2022
Durvalumab consolidation in patients with unresectable stage III non-small cell lung cancer with driver genomic alterations.
Journal: European journal of cancer (Oxford, England : 1990)
Published: January 13, 2022
A Definitive Prognostication System for Patients With Thoracic Malignancies Diagnosed With Coronavirus Disease 2019: An Update From the TERAVOLT Registry.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: October 30, 2021
Last Updated: 09/26/2026